Protection against Doxorubicin-Related Cardiotoxicity by Jaceosidin Involves the Sirt1 Signaling Pathway

The clinical use of doxorubicin (DOX) is largely limited by its cardiotoxicity. Previous studies have shown that jaceosidin has many biological activities. However, little is known about whether jaceosidin can attenuate DOX-related acute cardiotoxicity. Here, we investigated the therapeutic effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yuzhou, Zhou, Liying, Du, Binbin, Liu, Yuan, Xing, Junhui, Guo, Sen, Li, Ling, Chen, Hongrui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371661/
https://www.ncbi.nlm.nih.gov/pubmed/34422218
http://dx.doi.org/10.1155/2021/9984330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371661/
https://www.ncbi.nlm.nih.gov/pubmed/34422218
http://dx.doi.org/10.1155/2021/9984330

Ejemplares similares